$1.67 Billion is the total value of ARMISTICE CAPITAL, LLC's 77 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 60.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | Sell | SPDR S&P 500 ETF TRput | $197,690,000 | +1.2% | 680,000 | -5.6% | 11.87% | -7.0% |
| EPC | Sell | EDGEWELL PERS CARE CO | $46,230,000 | -16.1% | 1,000,000 | -8.4% | 2.78% | -22.9% |
| MNKKQ | Sell | MALLINCKRODT PUB LTD CO | $45,137,000 | +0.8% | 1,540,000 | -35.8% | 2.71% | -7.4% |
| HOG | Sell | HARLEY DAVIDSON INC | $37,327,000 | -11.3% | 824,000 | -17.6% | 2.24% | -18.4% |
| ATRS | Sell | ANTARES PHARMA INC | $30,643,000 | -1.4% | 9,120,000 | -24.3% | 1.84% | -9.4% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $30,303,000 | -31.4% | 75,000 | -41.4% | 1.82% | -36.9% |
| DESP | Sell | DESPEGAR COM CORP | $26,385,000 | -21.0% | 1,564,000 | -1.8% | 1.58% | -27.3% |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $20,655,000 | -51.2% | 900,000 | -59.5% | 1.24% | -55.2% |
| GPS | Sell | GAP INC DEL | $15,117,000 | -45.7% | 524,000 | -39.1% | 0.91% | -50.1% |
| ZFGN | Sell | ZAFGEN INC | $13,607,000 | -11.3% | 1,164,000 | -22.4% | 0.82% | -18.5% |
| BLUE | Sell | BLUEBIRD BIO INC | $12,848,000 | -54.5% | 88,000 | -51.1% | 0.77% | -58.2% |
| CVS | Sell | CVS HEALTH CORP | $7,872,000 | -75.5% | 100,000 | -80.0% | 0.47% | -77.5% |
| SLDB | Sell | SOLID BIOSCIENCES INC | $7,738,000 | +20.7% | 164,000 | -8.9% | 0.46% | +10.7% |
| ACHN | Sell | ACHILLION PHARMACEUTICALS IN | $7,360,000 | -35.0% | 2,000,000 | -50.0% | 0.44% | -40.2% |
| CPRX | Sell | CATALYST PHARMACEUTICALS INC | $6,320,000 | +19.2% | 1,672,000 | -1.6% | 0.38% | +9.5% |
| TPX | Sell | TEMPUR SEALY INTL INC | $5,290,000 | -87.1% | 100,000 | -88.3% | 0.32% | -88.2% |
| ACHV | Exit | ACHIEVE LIFE SCIENCE INC | $0 | – | -62,000 | -100.0% | -0.02% | – |
| ONTX | Exit | ONCONOVA THERAPEUTICS INC | $0 | – | -1,688,235 | -100.0% | -0.04% | – |
| NOVN | Exit | NOVAN INC | $0 | – | -500,000 | -100.0% | -0.10% | – |
| CATB | Exit | CATABASIS PHARMACEUTICALS IN | $0 | – | -2,000,000 | -100.0% | -0.12% | – |
| STDY | Exit | STEADYMED LTD | $0 | – | -497,044 | -100.0% | -0.15% | – |
| AMZN | Exit | AMAZON COM INC | $0 | – | -2,000 | -100.0% | -0.22% | – |
| IPCI | Exit | INTELLIPHARMACEUTICS INTL IN | $0 | – | -8,600,000 | -100.0% | -0.25% | – |
| ZOES | Exit | ZOES KITCHEN INC | $0 | – | -593,321 | -100.0% | -0.38% | – |
| DSW | Exit | DSW INCcl a | $0 | – | -280,000 | -100.0% | -0.47% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -124,000 | -100.0% | -0.48% | – |
| YELP | Exit | YELP INCcl a | $0 | – | -200,000 | -100.0% | -0.51% | – |
| DEPO | Exit | DEPOMED INC | $0 | – | -1,177,900 | -100.0% | -0.51% | – |
| PZZA | Exit | PAPA JOHNS INTL INC | $0 | – | -250,000 | -100.0% | -0.83% | – |
| APRN | Exit | BLUE APRON HLDGS INCcl a | $0 | – | -4,000,000 | -100.0% | -0.88% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -112,000 | -100.0% | -0.91% | – |
| CELG | Exit | CELGENE CORP | $0 | – | -175,000 | -100.0% | -0.91% | – |
| EPC | Exit | EDGEWELL PERS CARE COcall | $0 | – | -350,000 | -100.0% | -1.15% | – |
| BGS | Exit | B & G FOODS INC NEW | $0 | – | -700,000 | -100.0% | -1.37% | – |
| SMPL | Exit | SIMPLY GOOD FOODS CO | $0 | – | -1,460,000 | -100.0% | -1.38% | – |
| TBPH | Exit | THERAVANCE BIOPHARMA INC | $0 | – | -1,180,000 | -100.0% | -1.75% | – |
| FRPT | Exit | FRESHPET INCcall | $0 | – | -1,000,000 | -100.0% | -1.79% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -428,000 | -100.0% | -1.87% | – |
| SEAS | Exit | SEAWORLD ENTMT INC | $0 | – | -1,576,000 | -100.0% | -2.25% | – |
| PZZA | Exit | PAPA JOHNS INTL INCcall | $0 | – | -750,000 | -100.0% | -2.48% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.